Latest News and Press Releases
Want to stay updated on the latest news?
-
MOORESTOWN, N.J., March 20, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company optimizing medication safety by deploying new medication...
-
MOORESTOWN, N.J., March 16, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC) a healthcare technology company optimizing medication safety by deploying new medication risk...
-
MOORESTOWN, N.J., March 15, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), Chairman and CEO Calvin H. Knowlton, PhD, recently conducted an interviewed with NPR’s Lisa...
-
MOORESTOWN, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc., (“TRHC”) (NASDAQ:TRHC) announced today that Chief Pharmacotherapy Officer Robert L. Alesiani, PharmD, BCGP, has...
-
MOORESTOWN, N.J., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company optimizing medication safety by deploying new medication risk...
-
MOORESTOWN, N.J., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC) previously announced that its subsidiary, SinfoníaRx, Inc., has partnered with The Health...
-
MOORESTOWN, N.J., Sept. 28, 2017 (GLOBE NEWSWIRE) -- CareKinesis, a division of Tabula Rasa HealthCare (NASDAQ:TRHC), today announced it will be holding its 9th Clinical Advisory Panel (CAP)...
-
MOORESTOWN, N.J., Sept. 11, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced...
-
MOORESTOWN, N.J., Aug. 29, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare Corporation (NASDAQ:TRHC), a healthcare technology company disrupting the field of medication safety, announces that the...
-
MOORESTOWN, N.J., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company optimizing medication safety by deploying new medication risk...